Effects of ginkgolide b, a platelet-activating factor inhibitor on insulitis in the spontaneously diabetic bb rat
Summary, in English
The BB rat spontaneously develops insulin-dependent diabetes mellitus (IDDM) in association with marked insulitis in the islets of Langerhans. Since platelet-activating factor (PAF-acether) is involved in allergic and inflammatory reactions, we tested a PAF antagonist, Ginkgolide B (BN 52021) for potential effects on islet inflammation and diabetes. Diabetes prone BB/Wor rats were treated daily from weaning at 25 days until 105 days of age with either saline (n = 30, controls), 10 (n = 25, low dose) or 20 (n = 30, high dose) mg/kg body weight of BN 52021. The overall incidence of IDDM was unaffected by treatment. Quantitative analysis of insulin area showed a dose-dependent protection of β cells by Ginkgolide B, reflected in a 6- (low dose) to 8-fold (high dose) (P < 0. 01-0. 005) increase in the insulin/glucagon cell ratio compared to the saline treated rats. Ginkgolide B reduced severe insulitis from 84% in the saline rats developing IDDM to 59% (n. s.) in the low and to 33% (P < 0. 001) in the high dose group. These data suggest that PAF inhibitors may prove useful in immunomodulator therapy of IDDM since β cells are preserved.
- Endocrinology and Diabetes
- Diabetes mellitus
- ISSN: 0891-6934